John Ebers, a beekeeper in Germany, was initially diagnosed with stage 3 colorectal cancer and did not immediately undergo genetic testing. This testing would have revealed the availability of medications effective against his specific cancer. Subsequently, a genetic test was performed, proving crucial for his treatment. The test identified potential therapeutic options tailored to his genetic makeup. This highlights a potential gap in initial cancer treatment protocols in Germany, where genetic analysis isn't always prioritized. Fortunately for Mr. Ebers, the later test ultimately led to a life-saving treatment path. The case underscores the importance of genetic testing in personalized cancer care.